CC
MRK icon

Cypress Capital’s Merck MRK Stock Holding History

Cypress Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.2M Sell
24,880
-751
-3% -$87.9K 0.86% 22
2026
Q1 		$3.08M Buy
25,631
+550
+2% +$63.5K 0.88% 22
2025
Q4 		$2.64M Sell
25,081
-433
-2% -$40.6K 0.74% 28
2025
Q3 		$2.14M Sell
25,514
-875
-3% -$72.1K 0.61% 38
2025
Q2 		$2.09M Sell
26,389
-34
-0.1% -$2.7K 0.61% 41
2025
Q1 		$2.37M Buy
26,423
+1,144
+5% +$107K 0.68% 31
2024
Q4 		$2.51M Buy
25,279
+272
+1% +$28K 0.72% 27
2024
Q3 		$2.84M Buy
25,007
+528
+2% +$62.7K 0.73% 24
2024
Q2 		$3.03M Sell
24,479
-192
-0.8% -$24.7K 0.76% 17
2024
Q1 		$3.26M Sell
24,671
-103
-0.4% -$12.7K 0.89% 17
2023
Q4 		$2.7M Buy
24,774
+137
+0.6% +$14.2K 0.77% 23
2023
Q3 		$2.54M Sell
24,637
-1,096
-4% -$118K 0.74% 20
2023
Q2 		$2.97M Buy
25,733
+298
+1% +$33.8K 0.85% 14
2023
Q1 		$2.71M Buy
25,435
+362
+1% +$39.1K 0.85% 13
2022
Q4 		$2.78M Buy
25,073
+41
+0.2% +$4.19K 0.87% 13
2022
Q3 		$2.16M Buy
25,032
+725
+3% +$64.7K 0.76% 22
2022
Q2 		$2.22M Buy
24,307
+424
+2% +$37.6K 0.32% 52
2022
Q1 		$1.96M Sell
23,883
-553
-2% -$43.6K 0.24% 70
2021
Q4 		$1.87M Buy
24,436
+1,781
+8% +$142K 0.21% 77
2021
Q3 		$1.7M Buy
22,655
+4,434
+24% +$337K 0.22% 72
2021
Q2 		$1.42M Buy
18,221
+2,461
+16% +$183K 1.38% 37
2021
Q1 		$1.16M Buy
15,760
+1,538
+11% +$113K 0.47% 52
2020
Q4 		$1.11M Sell
14,222
-14
-0.1% -$1.07K 0.5% 42
2020
Q3 		$1.09M Sell
14,236
-1,075
-7% -$84.2K 0.51% 42
2020
Q2 		$1.13M Buy
+15,311
New +$1.15M 0.5% 31
2019
Q4 		$986K Buy
11,367
+413
+4% +$33.9K 0.41% 31
2019
Q3 		$880K Buy
10,954
+565
+5% +$45.3K 0.4% 36
2019
Q2 		$831K Buy
+10,389
New +$795K 0.38% 34

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Cypress Capital's MRK Position: Q2 2026 in Review

Cypress Capital reduced its Merck (MRK) stake by 2.9% in Q2 2026, selling an estimated $87.9K and leaving 24,880 shares worth $3.2M. The position accounts for 0.86% of the portfolio, ranked #22.

Cypress Capital first reported a position in MRK in Q2 2019 and has held it in 28 quarters since. The position peaked at $3.26M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cypress Capital held 24,880 shares of Merck worth $3.2M as of Q2 2026.
  • Cypress Capital sold 751 Merck shares in Q2 2026, an estimated $87.9K.
  • Merck made up 0.86% of Cypress Capital's portfolio in Q2 2026, its #22 holding.
  • Cypress Capital first reported a position in Merck in Q2 2019 and has held it in 28 quarters since.
  • Cypress Capital's Merck position peaked at $3.26M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cypress Capital's 13F filing for Q2 2026, filed 17 Jul 2026.